Identification of prognostic biomarkers related to the tumor microenvironment in thyroid carcinoma

Jun-wei Du,Guo-quan Li,Yang-sen Li,Xin-guang Qiu
DOI: https://doi.org/10.1038/s41598-021-90538-3
IF: 4.6
2021-08-10
Scientific Reports
Abstract:Abstract Thyroid Carcinoma (THCA) is the most common endocrine tumor that is mainly treated using surgery and radiotherapy. In addition, immunotherapy is a recently developed treatment option that has played an essential role in the management of several types of tumors. However, few reports exist on the use of immunotherapy to treat THCA. The study downloaded the miRNA, mRNA and lncRNA data for THCA patients from the TCGA database ( https://portal.gdc.cancer.gov/ ). Thereafter, the tumor samples were divided into cold and hot tumors, based on the immune score of the tumor microenvironment. Moreover, the differentially expressed lncRNAs and miRNAs were obtained. Finally, the study jointly constructed a ceRNA network through differential analysis of the mRNA data for cold and hot tumors. The study first assessed the level of immune infiltration in the THCA tumor microenvironment then divided the samples into cold and hot tumors, based on the immune score. Additionally, a total of 568 up-regulated and 412 down-regulated DEGs were screened by analyzing the differences between hot and cold tumors. Thereafter, the study examined the differentially expressed genes for lncRNA and miRNA. The results revealed 629 differentially expressed genes related to lncRNA and 114 associated with miRNA. Finally, a ceRNA network of the differentially expressed genes was constructed. The results showed a five-miRNA hubnet, i.e., hsa-mir-204, hsa-mir-128, hsa-mir-214, hsa-mir-150 and hsa-mir-338. The present study identified the immune-related mRNA, lncRNA and miRNA in THCA then constructed a ceRNA network. These results are therefore important as they provide more insights on the immune mechanisms in THCA. The findings also provides additional information for possible THCA immunotherapy.
multidisciplinary sciences
What problem does this paper attempt to address?
The paper aims to address issues related to immunotherapy for thyroid cancer (THCA). Specifically, the research objectives include: 1. **Assessing the level of immune infiltration in the tumor microenvironment**: By analyzing the immune cell infiltration in thyroid cancer samples, the samples are classified into "cold" tumors and "hot" tumors. Hot tumors have a higher degree of immune infiltration, while cold tumors have a lower degree. 2. **Screening differentially expressed genes**: Comparing the differentially expressed genes (DEGs) between cold tumors and hot tumors, including mRNA, lncRNA, and miRNA, and constructing a competing endogenous RNA (ceRNA) network. The study found a total of 568 upregulated genes and 412 downregulated genes. 3. **Constructing the ceRNA network**: Based on the differentially expressed gene data, a ceRNA network was constructed to explore the role of these genes in the immune mechanism of thyroid cancer. The study identified five key miRNAs (hsa-mir-204, hsa-mir-128, hsa-mir-214, hsa-mir-150, and hsa-mir-338) that play important roles in THCA immunity. 4. **Identifying potential immunotherapy targets**: Through cross-analysis of different types of gene expression, potential therapeutic targets were identified, including negatively regulated immune genes and positively regulated immune genes. 5. **Predicting PD1/PDL-1 related immune cells**: Evaluating the correlation between PD1 (PDCD1) and PDL-1 (CD274) with immune cells and analyzing their impact on patient prognosis. In summary, this study aims to reveal the immune mechanisms of thyroid cancer through comprehensive analysis of various gene expression data in thyroid cancer samples, providing a theoretical basis for the future development of new immunotherapy methods.